Okay.
In your letter, you stated that not extending the consultation period entailed risks that you personally did not want to take as acting chair of the PMPRB, including withdrawal and/or non-marketing of medicine or, in the future, vaccines in a pandemic.
Did you ever hear of any direct or implied threat from the pharmaceutical industry, its representatives or its lobbyists that proceeding with PMPRB reform might jeopardize pandemic vaccine availability for Canadians?